These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1532133)

  • 21. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Association between uptake to lymphocytes from schizophrenic patients and therapeutic efficacy].
    Shimogawa S; Kaku H; Yoshimoto S; Nakane Y
    Yakubutsu Seishin Kodo; 1986 Jun; 6(2):239-46. PubMed ID: 2877529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properties of dopamine agonist and antagonist binding sites in mammalian retina.
    Makman MH; Dvorkin B; Horowitz SG; Thal LJ
    Brain Res; 1980 Aug; 194(2):403-18. PubMed ID: 6770965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterisation of dopamine receptors in insect (Apis mellifera) brain.
    Kokay IC; Mercer AR
    Brain Res; 1996 Jan; 706(1):47-56. PubMed ID: 8720491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated lymphocyte spiperone binding: a vulnerability factor for affective psychosis?
    Fartaçek R; Geretsegger C; Breitfuss A; Ackenheil M; Bondy B
    Biol Psychiatry; 1997 Jan; 41(1):107-10. PubMed ID: 8988800
    [No Abstract]   [Full Text] [Related]  

  • 26. [3H]spiroperidol binding on lymphocytes: changes in two different groups of schizophrenic patients and effect of neuroleptic treatment.
    Le Fur G; Zarifian E; Phan T; Cuche H; Flamier A; Bouchami F; Burgevin MC; Loo H; Gérard A; Uzan A
    Life Sci; 1983 Jan; 32(3):249-55. PubMed ID: 6130459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [3H]nemonapride and [3H]spiperone label equivalent numbers of D2 and D3 dopamine receptors in a range of tissues and under different conditions.
    Vile JM; D'Souza UM; Strange PG
    J Neurochem; 1995 Feb; 64(2):940-3. PubMed ID: 7830089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3H-spiroperidol binding sites in blood platelets.
    Khanna AS; Agrawal AK; Seth PK
    Biochem Biophys Res Commun; 1987 Aug; 146(3):983-8. PubMed ID: 3619946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple receptors for brain dopamine.
    Titeler M; Weinreich P; Sinclair D; Seeman P
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1153-6. PubMed ID: 418405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites.
    Boehme RE; Ciaranello RD
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3255-9. PubMed ID: 6166945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine receptors and the dopamine hypothesis of schizophrenia.
    Seeman P
    Synapse; 1987; 1(2):133-52. PubMed ID: 2905529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for the presence of D2 and 5-HT2 receptors in the human prefrontal cortex.
    Mita T; Kuno T; Nakai H; Tanaka C
    Jpn J Pharmacol; 1982 Dec; 32(6):1027-32. PubMed ID: 7161958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of [3H]nemonapride and [3H]spiperone binding on human dopamine D4 receptors.
    Hidaka K; Matsumoto M; Tada S; Tasaki Y; Yamaguchi T
    Neurosci Lett; 1995 Feb; 186(2-3):145-8. PubMed ID: 7777184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal glucocorticoid dependent increase of spiperone binding sites on lymphocytes from schizophrenics in vitro.
    Halbach M; Henning U
    Pharmacopsychiatry; 1989 Sep; 22(5):169-73. PubMed ID: 2813506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S; Markstein R
    J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spiperone binding capacity in lymphocytes of patients with alcohol- and drug-induced psychosis: preliminary results.
    Soyka M; Bondy B; Peuker B; Ackenheil M
    J Stud Alcohol; 1994 Jul; 55(4):503-7. PubMed ID: 7934059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--III. The effects of lesions in the parafascicular-intralaminar nuclei on D2 dopamine receptors and high affinity dopamine uptake.
    Kilpatrick IC; Jones MW; Pycock CJ; Riches I; Phillipson OT
    Neuroscience; 1986 Nov; 19(3):991-1005. PubMed ID: 2948134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relation between brain D2-dopamine receptors and 3H-spiperone binding sites of intact lymphocytes].
    Noguchi-kuno SA; Nakata C; Nishitani H
    Rinsho Shinkeigaku; 1983 Sep; 23(9):814-8. PubMed ID: 6232031
    [No Abstract]   [Full Text] [Related]  

  • 39. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.
    Urwyler S; Coward D
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):115-22. PubMed ID: 2951601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.
    Sibley DR; Creese I
    Mol Pharmacol; 1983 May; 23(3):585-93. PubMed ID: 6223205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.